🔎 Trials Near Me

Home › Multiple Sclerosis › Maryland › Baltimore

Multiple Sclerosis clinical trials in Baltimore, MD

7 studies for Multiple Sclerosis are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

RecruitingPhase 1
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

RecruitingObservational study
  • TG Therapeutics Investigational Trial Site, Baltimore
  • TG Therapeutics Investigational Trial Site, Glen Burnie · 9 mi away
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06433752

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

RecruitingPhase 3
  • Baltimore Veterans Affairs Medical Center- Site Number : 8400163, Baltimore
Ages 18 to 60 · All sexes · Updated Sep 15, 2026 · NCT07325292

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

RecruitingPhase 2
  • Sheppard Pratt, Towson · 8 mi away
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

RecruitingPhase 2
  • Johns Hopkins University, Baltimore
Ages 18 to 60 · All sexes · Updated Jul 17, 2026 · NCT07497399

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

RecruitingPhase 2
  • Johns Hopkins University, Baltimore
Ages 18 to 60 · All sexes · Updated Jun 9, 2026 · NCT06170970

Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

RecruitingPhase 4
  • Johns Hopkins University, Baltimore
Ages 18 to 65 · All sexes · Updated May 6, 2026 · NCT07389590

About Multiple Sclerosis

Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.

More about Multiple Sclerosis on MedlinePlus

Multiple Sclerosis trials in other cities

Other studies in Baltimore

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.